Abstract

SummaryDegradation products of fibrinogen and fibrin resulting from the hydrolytic action of plasmin, trypsin, chymotrypsin and papain were prepared and the two major polypeptide fragments were found to have inhibitory effects on the coagulation mechanism including inhibition of thromboplastin generation and inhibition of the conversion of the fibrinogen to fibrin. The inhibitory actions of each of the isolated components were characterized specifically for their role in each of these coagulation functions.Both the slow (D) and fast (E) fragments of fibrinogen and fibrin hydrolysis by plasmin degradation showed equally inhibitory effects against fibrinogen to fibrin conversion by thrombin and fibrin monomer polymerization. The slow component of both was more inhibitory. Both fast and slow digestion products of tryptic hydrolysis inhibited thromboplastin generation and fibrinogen to fibrin conversion and fibrin monomer polymerization equally. The fast component of chymotrypsin hydrolysis showed greater inhibition against thromboplastin generation and fibrin monomer polymerization, than did the slow component. Only a slow moving (D) component was obtained with papain digestion. It had no inhibitory function against thromboplastin generation and only minimal effect against fibrin monomer polymerization. The mechanism of inhibition of the thromboplastin generation test by fibrinogen degradation products is a neutralization or inhibition of factor IX.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.